肝がん患者に対する標準ケア計画の構築と臨床評価

概要

論文の詳細を見る
We describe a pharmaceutical care plan for liver cancer patients based on pharmaceutical management methods. There is a checklist for the major points of the plan and by using it, we were able to identify the pharmaceutical problems and conduct interventions to solve them. We evaluated the clinical efficacy of the pharmaceutical care plan. Our subjects were liver cancer patients who were hospitalized in the Department of Gastroenterology from March to October, 2004. The pharmaceutical care plan was implemented in the last four months of this period and a comparison was made between a group of patients in whom its interventions were applied and a control group. In our study, we evaluated the pharmaceutical problems, pharmacist interventions, and the number of times patients receive guidance. The checklist suggested that pharmacist interventions be conducted for specific problems and included guidance for treatment from the time of admission to discharge. The control group comprised 30 patients (7 females, 23 males; mean age, 70 years), and the intervention group comprised 48 patients (8 females, 40 males; mean age, 68 years). As compared with the control group, there was a 2.9-fold increase in the total number of pharmaceutical problems addressed in the intervention group and there was a 2.8-fold increase in the total number of pharmacist interventions, both of these differences being significant. In the intervention group there was a 1.2- fold increase in the number of times patients received guidance over the control group but this difference was not significant. Based on these results, the pharmaceutical care plan is considered to be effective for improving the quality of patient care and pharmaceutical care for liver cancer patients.
日本医療薬学会の論文
2006-06-10

肝がん患者に対する標準ケア計画の構築と臨床評価

スポンサーリンク

概要

著者

関連論文

スポンサーリンク